|
注册号: Registration number: |
ChiCTR1900028364 |
|
最近更新日期: Date of Last Refreshed on: |
2021-06-21 23:00:46 |
|
注册时间: Date of Registration: |
2019-12-20 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
智能影像辅助诊断技术在脑出血中的应用与推广 |
|
Public title: |
Development and Application of the Artificial Intelligence-Assisted Diagnosis System for Intracranial Hemorrhage |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
智能影像辅助诊断技术在脑出血中的应用与推广 |
|
Scientific title: |
Development and Application of the Artificial Intelligence-Assisted Diagnosis System for Intracranial Hemorrhage |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
赵娴靓 |
研究负责人: |
姚振威 |
|
Applicant: |
Xianjing Zhao |
Study leader: |
Zhenwei Yao |
|
申请注册联系人电话: Applicant telephone: |
+86 021-52888354 |
研究负责人电话:
Study leader's |
+86 021-52888354 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
102268793@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
zwyao@fudan.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市乌鲁木齐中路12号 |
研究负责人通讯地址: |
上海市乌鲁木齐中路12号 |
|
Applicant address: |
12 Middle Urumqi Road, Shanghai, China |
Study leader's address: |
12 Middle Urumqi Road, Shanghai, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
复旦大学附属华山医院 |
||
|
Applicant's institution: |
Huashan Hospital, Fudan University |
||
|
研究负责人所在单位: |
复旦大学附属华山医院 |
||
|
Affiliation of the Leader: |
Huashan Hospital, Fudan University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2019-437 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
复旦大学附属华山医院伦理审查委员会 |
||
|
Name of the ethic committee: |
Huashan Hospital, Fudan University, Institutional Review Board |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2019-10-15 00:00:00 | ||
|
伦理委员会联系人: |
范维琥 |
||
|
Contact Name of the ethic committee: |
Fan Weihu |
||
|
伦理委员会联系地址: |
上海市乌鲁木齐中路12号 |
||
|
Contact Address of the ethic committee: |
12 Middle Urumqi Road, Shanghai, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 021-52888045 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
复旦大学附属华山医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Huashan Hospital, Fudan University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国上海乌鲁木齐中路12号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
12 Middle Urumqi Road, Shanghai, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
上海市卫生健康委员会 |
||||||||||||||||||||||
|
Source(s) of funding: |
Shanghai Municipal Health Commission |
||||||||||||||||||||||
|
研究疾病: |
脑出血 |
||||||||||||||||||||||
|
Target disease: |
intracerebral haemorrhage |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
诊断试验 |
||||||||||||||||||||||
|
Study type: |
Diagnostic test |
||||||||||||||||||||||
|
研究所处阶段: |
回顾性研究 | ||||||||||||||||||||||
|
Study phase: |
Retrospective study |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
本项目拟通过推广AI辅助CT卒中阅片系统。AI辅助放射科和急诊科医生阅片,提供各类定量分析数据,从而解决临床上出血量少的时候容易漏检,出血量大难以定量等一系列问题。同时还提供二次出血预警,脑疝预警等一系列预警机制,更好地助力临床治疗决策。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study aims to develop an artificial intelligence-assisted diagnosis system to help doctors read CT images of intracranial hemorrhage patients and provide quantitative analysis data, so as to solve a series of clinical problems such as miss abnormalities and precisely measure the volume of intracranial hemorrhage. This system also intends to guide risk estimates like hematoma expansion and herniation, together with subsequent management decisions |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1)运动伪影严重,图像质量差。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Serious motion artifacts and poor image quality; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2020-01-31 00:00:00至 To 2022-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2020-02-01 00:00:00 至 To 2022-06-30 00:00:00 |
|
诊断试验: Diagnostic Tests: |
|
||||||||||||||||||||||||||||
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
不适用 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Not applicable |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
未说明 |
|
Blinding: |
Not stated |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
共享原始数据于文章发表后6个月内公开 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Share IPD within six months after the trial complete |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Electronic Data Capture |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |